Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 July 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 206 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 74 results:
Author Title [ Type(Desc)] Year
Filters: Author is Garcia Rodriguez, L. A.  [Clear All Filters]
Journal Article
C. Huerta, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom”, Arch Intern Med, vol. 167, pp. 935-43, 2007.
L. A. Garcia Rodriguez, Wallander, M. A., and Stricker, B. H., “The risk of acute liver injury associated with cimetidine and other acid-suppressing anti-ulcer drugs”, Br J Clin Pharmacol, vol. 43, pp. 183-8, 1997.
L. A. Garcia Rodriguez, Stricker, B. H., and Zimmerman, H. J., “Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid”, Arch Intern Med, vol. 156, pp. 1327-32, 1996.
C. Huerta, Zhao, S. Z., and Rodriguez, L. A. Garcia, “Risk of acute liver injury in patients with diabetes”, Pharmacotherapy, vol. 22, pp. 1091-6, 2002.
L. A. Garcia Rodriguez and Gonzalez-Perez, A., “Risk of breast cancer among users of aspirin and other anti-inflammatory drugs”, Br J Cancer, vol. 91, pp. 525-9, 2004.
A. Ruigomez, Rodriguez, L. A. Garcia, Johansson, S., Wallander, M. A., and Edvardsson, N., “Risk of cerebrovascular accident after a first diagnosis of atrial fibrillation”, Clin Cardiol, vol. 30, pp. 624-8, 2007.
C. Huerta and Rodriguez, L. A. Garcia, “Risk of clinical blood dyscrasia in a cohort of antibiotic users”, Pharmacotherapy, vol. 22, pp. 630-6, 2002.
L. A. Garcia Rodriguez and Jick, H., “Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs”, Bmj, vol. 308, pp. 503-6, 1994.
L. A. Garcia Rodriguez, Cattaruzzi, C., Troncon, M. G., and Agostinis, L., “Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs”, Arch Intern Med, vol. 158, pp. 33-9, 1998.
C. Huerta, Rodriguez, L. A. Garcia, Wallander, M. A., and Johansson, S., “Risk of irritable bowel syndrome among asthma patients”, Pharmacoepidemiol Drug Saf, vol. 11, pp. 31-5, 2002.
A. Ruigomez, Johansson, S., Wallander, M. A., and Rodriguez, L. A. Garcia, “Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation”, BMC Cardiovasc Disord, vol. 2, p. 5, 2002.
C. Huerta, Rodriguez, L. A. Garcia, Moller, C. S., and Arellano, F. M., “The risk of obstructive airways disease in a glaucoma population”, Pharmacoepidemiol Drug Saf, vol. 10, pp. 157-63, 2001.
L. A. Garcia Rodriguez and Jick, H., “Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs”, Lancet, vol. 343, pp. 769-72, 1994.
F. J. de Abajo and Rodriguez, L. A. Garcia, “Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations”, BMC Clin Pharmacol, vol. 1, p. 1, 2001.
L. A. Garcia Rodriguez and Hernandez-Diaz, S., “The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents”, Arthritis Res, vol. 3, pp. 98-101, 2001.
L. A. Garcia Rodriguez and Ruigomez, A., “Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed”, Epidemiology, vol. 10, pp. 228-32, 1999.
M. A. Wallander, Johansson, S., Ruigomez, A., and Rodriguez, L. A. Garcia, “Unspecified abdominal pain in primary care: the role of gastrointestinal morbidity”, Int J Clin Pract, vol. 61, pp. 1663-70, 2007.
L. A. Garcia Rodriguez and Gonzalez-Perez, A., “Use of antibiotics and risk of breast cancer”, Am J Epidemiol, vol. 161, pp. 616-9, 2005.
A. Ruigomez, Rodriguez, L. A. Garcia, Cattaruzzi, C., Troncon, M. G., Agostinis, L., Wallander, M. A., and Johansson, S., “Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes”, Am J Epidemiol, vol. 150, pp. 476-81, 1999.
L. A. Garcia Rodriguez, Johansson, S., and L. Soriano, C., “Use of clopidogrel and proton pump inhibitors after a serious acute coronary event: risk of coronary events and peptic ulcer bleeding”, Thromb Haemost, vol. 110, pp. 1014-24, 2013.
L. A. Garcia Rodriguez and S. Gutthann, P., “Use of the UK General Practice Research Database for pharmacoepidemiology”, Br J Clin Pharmacol, vol. 45, pp. 419-25, 1998.
C. Huerta, Rodriguez, L. A. Garcia, Wallander, M. A., and Johansson, S., “Users of oral steroids are at a reduced risk of developing irritable bowel syndrome”, Pharmacoepidemiol Drug Saf, vol. 12, pp. 583-8, 2003.
S. S. Jick, Kaye, J. A., Vasilakis-Scaramozza, C., Rodriguez, L. A. Garcia, Ruigomez, A., Meier, C. R., Schlienger, R. G., Black, C., and Jick, H., “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
D. Henry, Lim, L. L., Rodriguez, L. A. Garcia, S. Gutthann, P., Carson, J. L., Griffin, M., Savage, R., Logan, R., Moride, Y., Hawkey, C., Hill, S., and Fries, J. T., “Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis”, Bmj, vol. 312, pp. 1563-6, 1996.
[Page last reviewed 6 July 2020]